Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT01 and Comp01-04 in Actinic Keratosis
NCT02126670Phase 2Completed
- Sponsor
- Promius Pharma
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of privosegtor in actinic keratosis (AK), sponsored by Promius Pharma. Started Apr 2014; status: completed.
02
Drugs
privosegtor
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02126670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126670.